![](/img/cover-not-exists.png)
Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis
Whittington, Melanie D., McQueen, R. Brett, Ollendorf, Daniel A., Tice, Jeffrey A., Chapman, Richard H., Pearson, Steven D., Campbell, Jonathan D.Volume:
118
Language:
english
Journal:
Annals of Allergy, Asthma & Immunology
DOI:
10.1016/j.anai.2016.10.028
Date:
February, 2017
File:
PDF, 542 KB
english, 2017